logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Portal, Thibaud, Dr
    Born in November 1970
    Individual (4 offsprings)
    Officer
    icon of calendar 2023-02-01 ~ now
    OF - Director → CIF 0
Ceased 6
  • 1
    Coleman, James Edward, Dr
    Director born in July 1975
    Individual (11 offsprings)
    Officer
    icon of calendar 2017-03-03 ~ 2023-10-12
    OF - Director → CIF 0
    Dr James Edward Coleman
    Born in July 1975
    Individual (11 offsprings)
    Person with significant control
    icon of calendar 2017-03-03 ~ 2017-04-06
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    De Rubertis, Francesco
    Investor born in January 1970
    Individual (19 offsprings)
    Officer
    icon of calendar 2020-11-13 ~ 2023-10-18
    OF - Director → CIF 0
  • 3
    Edwards, Jon
    Invester born in October 1983
    Individual (1 offspring)
    Officer
    icon of calendar 2017-04-06 ~ 2020-11-13
    OF - Director → CIF 0
  • 4
    Johnson, Kevin Stuart, Dr
    Investor born in August 1960
    Individual (9 offsprings)
    Officer
    icon of calendar 2017-04-06 ~ 2022-02-09
    OF - Director → CIF 0
  • 5
    Finlay, William James Jonathan, Dr
    Director born in February 1974
    Individual (11 offsprings)
    Officer
    icon of calendar 2017-03-03 ~ 2023-10-18
    OF - Director → CIF 0
    Dr William James Jonathan Finlay
    Born in February 1974
    Individual (11 offsprings)
    Person with significant control
    icon of calendar 2017-03-03 ~ 2017-04-06
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 6
    TCPI ASSET 1 LIMITED - 2013-04-10
    icon of addressBridge House, 25 Fiddlebridge Lane, Hatfield, Hertfordshire, United Kingdom
    Active Corporate (4 parents, 32 offsprings)
    Equity (Company account)
    805,306 GBP2018-04-30
    Officer
    2017-03-03 ~ 2017-07-28
    PE - Secretary → CIF 0
parent relation
Company in focus

GRANULAR THERAPEUTICS LIMITED

Previous name
ULTRAHUMAN FIVE LIMITED - 2021-02-04
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
52023-01-01 ~ 2023-12-31
42022-01-01 ~ 2022-12-31
Property, Plant & Equipment
386 GBP2022-12-31
Fixed Assets - Investments
18,129 GBP2023-12-31
Debtors
Current
849,480 GBP2023-12-31
710,740 GBP2022-12-31
Cash at bank and in hand
250,540 GBP2023-12-31
1,375,448 GBP2022-12-31
Current Assets
1,100,020 GBP2023-12-31
2,086,188 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-280,953 GBP2022-12-31
Net Current Assets/Liabilities
-548,474 GBP2023-12-31
1,805,235 GBP2022-12-31
Net Assets/Liabilities
-530,345 GBP2023-12-31
1,805,621 GBP2022-12-31
Equity
Called up share capital
94 GBP2023-12-31
68 GBP2022-12-31
68 GBP2022-01-01
Share premium
7,403,104 GBP2023-12-31
5,232,987 GBP2022-12-31
5,232,987 GBP2022-01-01
Retained earnings (accumulated losses)
-7,933,543 GBP2023-12-31
-3,427,434 GBP2022-12-31
-1,819,175 GBP2022-01-01
Equity
-530,345 GBP2023-12-31
1,805,621 GBP2022-12-31
3,413,880 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-4,506,109 GBP2023-01-01 ~ 2023-12-31
-1,608,259 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-4,506,109 GBP2023-01-01 ~ 2023-12-31
-1,608,259 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-4,506,109 GBP2023-01-01 ~ 2023-12-31
-1,608,259 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
-4,506,109 GBP2023-01-01 ~ 2023-12-31
-1,608,259 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
Called up share capital
26 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
2,170,143 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
Called up share capital
26 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
2,170,143 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Depreciation rate used
Office equipment
252023-01-01 ~ 2023-12-31
Wages/Salaries
90,000 GBP2023-01-01 ~ 2023-12-31
90,000 GBP2022-01-01 ~ 2022-12-31
Social Security Costs
1,979 GBP2023-01-01 ~ 2023-12-31
10,387 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
98,650 GBP2023-01-01 ~ 2023-12-31
105,187 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
1,546 GBP2023-12-31
1,546 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
1,160 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
1,546 GBP2023-12-31
Property, Plant & Equipment
Office equipment
386 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
2,357 GBP2023-12-31
Other Debtors
Current
845,965 GBP2023-12-31
532,833 GBP2022-12-31
Prepayments/Accrued Income
Current
1,158 GBP2023-12-31
177,907 GBP2022-12-31
Bank Overdrafts
Current
916 GBP2022-12-31
Trade Creditors/Trade Payables
Current
544,690 GBP2023-12-31
139,429 GBP2022-12-31
Taxation/Social Security Payable
Current
3,751 GBP2023-12-31
Other Creditors
Current
1,026,988 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
73,065 GBP2023-12-31
140,608 GBP2022-12-31
Creditors
Current
1,648,494 GBP2023-12-31
280,953 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
9,431,124 shares2023-12-31
200,000 shares2022-12-31
Par Value of Share
Class 1 ordinary share
0.000012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
800,000 shares2022-12-31
Par Value of Share
Class 2 ordinary share
0.000012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
4,497,000 shares2022-12-31
Par Value of Share
Class 3 ordinary share
0.000012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
1,124,000 shares2022-12-31
Par Value of Share
Class 4 ordinary share
0.000012023-01-01 ~ 2023-12-31
  • GRANULAR THERAPEUTICS LIMITED
    Info
    ULTRAHUMAN FIVE LIMITED - 2021-02-04
    Registered number 10650696
    icon of addressC/o Kreston Reeves Llp Innovation House, Ramsgate Road, Sandwich, Kent CT13 9FF
    PRIVATE LIMITED COMPANY incorporated on 2017-03-03 (8 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-21
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.